How we are contributing to global pharmaceutical standards
The evolving global pharmaceutical regulatory environment and the increasing interest of new countries in joining the ICH highlights the importance of maintaining consistent interpretation and implementation of ICH guidelines among industry and regulatory authorities worldwide.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), along with other ICH Members and Observers, has an important role in promoting global convergence toward ICH regulatory standards and their harmonized interpretation.
Download this two-pager to learn more about how IFPMA represents the pharmaceutical industry in ICH.
Related news and resources
The use of artificial intelligence in regulatory activities – key areas and considerations
Scientific innovation is transforming the way medicines are discovered, developed, and evaluated, creating new opportunities to generate and analyze increasingly complex data and evidence. Regulatory science and regulatory systems need to evolve alongside these advances to ensure that scientific innovation can be effectively translated into innovative medicines for patients. Against this backdrop, artificial intelligence offers...
Read more
76th WHO Regional Committee for Africa: Regional strategy on regulation of medical products in the African region, 2026-2035
On 26 August 2026, IFPMA delivered a statement on the regional strategy on regulation of medical products in the African region, 2026-2035, during the 76th WHO Regional Committee for Africa in Addis Ababa, Ethiopia. IFPMA welcomes the proposed Strategy on Regulation of Medical Products, and commends WHO AFRO, Member States, and regional institutions for their...
Read moreAMATA Statement at WHO Regional Committee for Africa: Regional strategy on regulation of medical products in the African Region, 2026-2035
The members of the African Medicines Agency Treaty Alliance (AMATA) welcome and strongly support the Regional Strategy on Regulation of Medical Products in the African Region, 2026–2035. Access to safe, effective, quality-assured medical products depends on a strong regulatory system. However, a truly harmonized and effective regulatory system cannot be achieved without continental coordination and...
Read more